AMEX · Biotechnology

PLX (PLX) Stock

$2.40 +1.27% AMEX: PLX Healthcare

Valuation

MetricValue
Price$2.40
Market Cap$193.37M
P/E Ratio-25.12
P/B Ratio3.37
P/S Ratio2.12
EPS (TTM)$-0.08
52-Week High$3.19
52-Week Low$1.32
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-14.58%
ROA-8.54%
ROCE-10.42%
Gross Margin-9.43%
Operating Margin-9.43%
Net Margin20.07%
Debt/Equity0.13
Current Ratio2.48

Annual Financials (USD)

Metric20212022202320242025
Revenue$38.0M$48.0M$65.0M$53.0M$53.0M
Operating Profit$-20.0M$-13.0M$10.0M$4.0M$-5.0M
Net Profit$-28.0M$-15.0M$8.0M$3.0M$-7.0M
EPS$-0.62$-0.31$0.10$0.04$-0.08
Op Margin-53.4%-27.3%16.0%7.3%-10.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$74.0M$56.0M$84.0M$73.0M$82.0M
Total Liabilities$80.0M$66.0M$51.0M$30.0M$34.0M
Cash$39.0M$17.0M$24.0M$20.0M$15.0M
Borrowings$33.0M$33.0M$28.0M$6.0M$8.0M

Latest News

3 Penny Stocks With Market Caps Larger Than $100M To Consider Simply Wall St. · May 26, 2026 PLX: Chiesi Milestone Received Zacks Small Cap Research · May 14, 2026 Protalix BioTherapeutics, Inc. Q1 2026 Earnings Call Summary Moby · May 14, 2026 Protalix BioTherapeutics Inc (PLX) Q1 2026 Earnings Call Highlights: Strong Financial Position ... GuruFocus.com · May 13, 2026 Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call Benzinga · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-10.0M$-25.0M$-1.0M$9.0M$-12.0M
Investing Cash Flow$17.0M$-6.0M$-18.0M$3.0M$-4.0M
Financing Cash Flow$0$0$1.0M$0$0
Net Cash Flow$21.0M$-22.0M$7.0M$-4.0M$-4.0M
Free Cash Flow$-12.0M$-26.0M$-2.0M$7.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield9.04%
Quick Ratio2.04
Interest Coverage-5.00
Return 1Y62.68%
Return 3Y29.05%
Return 5Y46.20%

Ownership

Insiders Held3.88%
Institutions Held20.81%
Institutions Float Held21.65%
Institutional HolderSharesReport Date
Blackrock Inc.3,616,9622026-03-31
MAK Capital One LLC3,544,1392026-03-31
Renaissance Technologies, LLC1,224,8002026-03-31
State Street Corporation972,8152026-03-31
Northern Trust Corporation885,4482026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CDXS $1.47 -2.00% -5.06 $133.62M 0.00%
CHRS $1.27 +0.40% -2.21 $155.46M 0.00%
GNFTGenfit S.A. $8.95 +4.07% 261.07 $445.68M 0.00%
IVVD $0.55 +3.10% -3.53 $162.51M 0.00%
MDWD $14.35 -1.85% -7.94 $184.34M 0.00%

About PLX

PLX is led by CEO Dror Bashan, employs 213 people, headquartered in US, publicly traded since 1998.

PLX stock trades at $2.40 with a market capitalization of $193.37M. The stock is valued at a price-to-earnings (P/E) ratio of -25.12, price-to-book of 3.37, price-to-sales of 2.12. Over the past 52 weeks the stock has ranged between $1.32 and $3.19, and currently trades 24.8% below its 52-week high.

On profitability, PLX generates a return on equity (ROE) of -14.58%, return on capital employed of -10.42%, an operating margin of -9.43%, a net profit margin of 20.07%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides